Natrol Q2 earnings
This article was originally published in The Tan Sheet
Executive Summary
Natrol reported net income of $100,000 on net sales of $16.6 mil. during the second-quarter (ended June 30) marking the company's "second consecutive quarter of profitability," Natrol President and CEO Wayne Bos said Aug. 14. The gains represented a turnaround from the first two quarters of 2005 when Natrol reported a net loss of $300,000 on net sales of $37.3 mil. "We have achieved profitability by being sharply-focused on the core business," Bos said...
You may also be interested in...
Natrol Sees More Deals In The Future; Looks To Tailor, Balance Portfolio
An exclusive manufacturing and distribution deal with H57 Nutrition for Original South African H57 Hoodia is a feather in Natrol's cap following several acquisitions and licensing deals in the past three weeks
Biogen ‘Ready To Launch’ Aducanumab If It Gets The Chance
The company has identified 600 sites of care to treat Alzheimer's patients with aducanumab in the US and is confident on its pricing strategy, management said.
Intuitive Exceeds Expectations In Q1 As Da Vinci Sales And Surgeries Recover
The robotic surgery company recorded $1.29bn in first-quarter revenue, an 18% year-over-year increase. Worldwide da Vinci procedures were up 16% as surgical volumes recovered from the pandemic.